Tags: Drug.

Certolizumab pegol (CDP870 tradename Cimzia) is a therapeutic monoclonal antibody to tumor necrosis factor alpha (TNF-α) for the treatment of Crohn’s disease and rheumatoid arthritis manufactured by UCB.

ATC prefix
L04
ATC suffix
AB05
CAS number
428863-50-7
FDA UNII code
UMD07X179E

Loading...

This page contains content from the copyrighted Wikipedia article "Certolizumab pegol"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.